Alpha Diagnostics International Inc Company Profile

16:35 EDT 17th March 2018 | BioPortfolio

Alpha Diagnostic International (ADI) located in San Antonio, Texas, USA, is a major provider of custom services such as peptides synthesis and polyclonal antibodies. ADI specializes in the development, manufacture, and distribution of variety of ELISA reagents and kits for animal and human research. ADI maintains an USDA inspected and approved, animal facility. We have introduced a number of specialized antibodies to a variety of new genes including obese/leptin, membrane receptors, and neurotransmitter transporters.


5415 Lost Lane
San Antonio
United States of America


Phone: (210) 561-9515
Fax: (210) 561-9544

News Articles [772 Associated News Articles listed on BioPortfolio]

New Partnership for Biological Sample Transport Solutions

Specialist Laboratory and Diagnostics supply company Alpha Laboratories Ltd. is delighted to announce that it has been appointed the exclusive UK distributor for MedDX Solutions Ltd. This partner...

First John W. Walsh Translational Research Award granted

(Boston University School of Medicine) The Alpha-1 Foundation celebrates the first granting of the John W. Walsh Translational Research Award in Alpha-1 Antitrypsin Deficiency, an honorable award name...

Bruker Launches the ALPHA II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control

Bruker launch the new ALPHA II, the latest generation of the ALPHA series of compact FTIR spectrometers. The ALPHA II features fully-automated test routines for validation regarding operati...

A new approach for detecting planets in the Alpha Centauri system

Abituzumab may be potential treatment for scleroderma

SAN DIEGO — Abituzumab has the potential to block TGF-beta-induced fibroblast to myofibroblast transition, and deter fibrosis development, according to Eileen Samy, PhD, a senior scientist specializ...

BioVendor Acquires All Shares of DIAsource ImmunoAssays SA

BioVendor - Laboratornímedicínaa.s., an international diagnostics holding, has acquired 100% of the shares of DIAsourceImmunoAssays SA from Anteo Diagnostics, which...

Kamada and Chiesi Farmaceutici S.p.A. Mutually Agree to Terminate European Distribution Agreement for Inhaled Alpha-1 Antitrypsin Therapy for Treatment of Alpha-1 Antitrypsin Deficiency

Following Kamada’s Recent Withdrawal of European Marketing Authorization Application, Distribution Agreement Not Currently Warranted REHOVOT, Israel, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Kamada ...

Teilnahme von Pharnext an Investorenkonferenzen im November

Pharnext SA (FR0011191287 ALPHA) (Paris: ALPHA), ein biopharmazeutisches Unternehmen mit einem neuartigen Ansatz für die Entwicklung innovativer Arzneimittel, der auf der Kombination und Neupositi...

PubMed Articles [1341 Associated PubMed Articles listed on BioPortfolio]

Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus Immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay.

As part of the scientific community's development of medical countermeasures against Ebola virus disease, optimization of standardized assays for product evaluation is paramount. The recent outbreak h...

A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.

To assess a new and highly specific, but low-cost, easily performed and suitable for large-scale applications method for renal fibrosis (RF) diagnostics.

Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.

In Alzheimer's disease (AD) research, both 2-deoxy-2-((18)F)fluoro-D-glucose (FDG) positron emission tomography (PET) and electroencephalography (EEG) are reliable investigational modalities. The aim ...

Diagnostic accuracy of alpha-defensin in periprosthetic joint infection: a systematic review and meta-analysis.

Alpha-defensin, a novel biomarker, has shown great potential for the accurate diagnosis of periprosthetic joint infection (PJI) in recent years: many published studies have presented encouraging resul...

Postanoxic alpha, theta or alpha-theta coma: clinical setting and neurological outcome.

The aim of this study was to determine the prognosis of 26 consecutive adults with alpha coma (AC), theta coma (TC) or alpha-theta coma (ATC) following CRA and to describe the clinical setting and EEG...

Clinical Trials [1943 Associated Clinical Trials listed on BioPortfolio]

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

This is an evaluation of the effectiveness of darbepoetin alpha in treating anemia of MDS patients with an International Prognostic Scoring System (IPSS) score of low or intermediate 1.

Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation

Prospective, blinded, multicenter international trial to test the Preventicus Heartbeats App in a prospective cohort.

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Companies [2261 Associated Companies listed on BioPortfolio]

Alpha Diagnostics International Inc

Alpha Diagnostic International (ADI) located in San Antonio, Texas, USA, is a major provider of custom services such as peptides synthesis and polyclonal antibodies. ADI specializes in the development...

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...


Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

More Information about "Alpha Diagnostics International Inc" on BioPortfolio

We have published hundreds of Alpha Diagnostics International Inc news stories on BioPortfolio along with dozens of Alpha Diagnostics International Inc Clinical Trials and PubMed Articles about Alpha Diagnostics International Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alpha Diagnostics International Inc Companies in our database. You can also find out about relevant Alpha Diagnostics International Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Corporate Database Quicklinks

Searches Linking to this Company Record